tirzepatide efectos secundarios a largo plazo Disminuye los de tirzepatide.. #diabetes #obesida Tirzepatida? El fármaco más polémico

Semaglutide activates GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetitebut this same mechanism can trigger dizziness in up to 25% of users during the first weeks of treatment

As a heat wave sweeps over much of the country, with triple-digits possible in some places, the high temperatures carry an extra risk for millions of people taking GLP-1 medications like Ozempic or Wegovy

The demographics tell a striking story

Insulin resistance (an impaired response to insulin that results in elevated glucose levels) affects around 65-70% of women with PCOS, and for those also living with obesity, that number climbs to 70-80%

Many patients relied on unapproved versions of Wegovy and Ozempic since compounding pharmacies are allowed to make versions of branded medications in short supply